CV19 Lab Testing Dashboard powered by hc1
To support health care providers and public health agencies in responding to the COVID-19 pandemic,
hc1 is leading a coalition of 20K+ lab testing locations to power the CV19 Lab Testing Dashboard.

By Dr. Peter J. Plantes

July 28, 2020

hc1 has been keeping an eye on the counties facing the most rapidly expanding challenge from the spread of COVID-19. The CV19 Lab Testing Dashboard™ powered by hc1 provides hyperlocal insights for all 3,007 counties in the United States including index factors that can indicate a rapid increase in the percent positivity [% (+)] of SARS-CoV-2 viral tests.  

The “top 10” counties we have identified have a population >100,000, more than 100 COVID-19 viral tests performed in the past week, an hc1 Local Risk Index™ (LRI) >7, and an acceleration factor of LRI equal to or greater than 1.5 (see my earlier post for a full explanation of LRI). 

Top 10 Counties with the Largest Magnitude of Change determined by LRI x ‘7vs7’ rate for July 27, 2020

covid19 data

For a community of 100,000, a rapid rise in the presence of positive COVID-19 viral testing is the earliest indicator that ER, hospital, ICU, ventilators, and other medical resources (clinical providers, PPE, facilities, etc.) will be heavily taxed in the next 10 to 21 days. The community that has the largest acceleration in positive tests week-over-week will see the fastest rise in the magnitude of COVID-19 cases. 

The first week of COVID-19 symptoms are typically milder. It is in the second week that sicker patients seek acute care and hospitalization for advancing symptoms. A larger portion of the healthy population will get tested when a potential contact with another COVID-19 positive individual is suspected. This expansion of testing will begin to capture the 30–45% asymptomatic and presymptomatic cases. The more widespread the testing, the earlier the warning will be of the future strain on medical resources from an increasing percent positive [% (+)] trend. 

Visit www.CV19Dashboard.org for your county’s current CV19 LRI and other CV19 lab testing insights. 

About the Author

Peter J. Plantes, M.D. has three decades of experience creating service and delivery solutions that enhance marketplace success and clinical performance for clinical practice groups, academic faculty group practices, hospitals, health systems, and health care organizations. His success stems from his ability to blend and synergize clinical knowledge, operational expertise, financial performance, and collaborative methodology with his deep commitment to serve patients and improve the health of the community. Dr. Plantes has served in CEO & Physician Executive roles for a number of large healthcare clinical delivery networks including regional community networks, academic practices, national hospital networks, international health systems (Chile, Colombia),  and corporate managed care/HMO networks.

Subscribe to the blog
Previous Post hc1 featured in KSM “Doing Great Things” series
Next Post Precision Prescribing in the Cloud: Serverless and Scalable